Scandinavian ChemoTech enters into an agreement with Erik Penser Bank to monitor the company in the form of assignment analyses
Scandinavian ChemoTech AB (publ) has entered into an agreement with Erik Penser Bank AB to receive the service, Penser Access, where written analysis reports are the central part of the service.The purpose of the agreement is to carry out a number of analyses that will aim to increase the stock market's knowledge of the company and provide indications of target prices. "It feels good that ChemoTech is now deepening its collaboration with Erik Penser Bank and will be giving the stock market access to analyses and descriptions of the company's potential, developed by well-experienced